Pneumonia News and Research

Latest Pneumonia News and Research

Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed patient enrollment in its Phase IIb study with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection.

29 Nov 2011

New glycoconjugate vaccine prototype more effective than traditional vaccines

Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.

29 Nov 2011

Pediatricians frequently asked to provide alternative childhood vaccine schedules

Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study from Seattle Children's Research Institute.

29 Nov 2011

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.

23 Nov 2011

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

21 Nov 2011

HHS, CCSC to recognize healthcare professionals with excellence in preventing HAIs

Teams of critical care professionals and healthcare institutions with a record of reducing or eliminating healthcare-associated infections (HAIs) are encouraged to submit their best practices to a national awards program.

19 Nov 2011

Potential new ways to design vaccines, antibiotics

A University of Louisville scientist has determined for the first time how the bacterium that causes Legionnaires' disease manipulates our cells to generate the amino acids it needs to grow and cause infection and inflammation in the lungs.

18 Nov 2011

New framework to improve care for patients with delirium

A new national plan of action provides a roadmap for improving the care of patients with delirium, a poorly understood and often unrecognized brain condition that affects approximately seven million hospitalized Americans each year.

18 Nov 2011

Complications from preventable surgical-site infections leading to hospital readmissions after colon surgery

Nearly one-quarter of privately insured colon surgery patients are readmitted to the hospital within three months of discharge at a cost of roughly $9,000 per readmission, according to Johns Hopkins researchers, who've identified a major area for quality improvement and cost reduction in health care.

17 Nov 2011

TNF inhibitors may minimally increase risk of serious infections

Biologic drugs have revolutionized treatment of autoimmune diseases during the past decade despite belief there is an increased risk for serious infections from using them. But new research from the University of Alabama at Birmingham Center for Education and Research on Therapeutics reveals that a class of biologics called tumor necrosis factor antagonists, or TNF inhibitors, may only minimally increase risk compared to more traditional therapies.

17 Nov 2011

Severity of smoke-inhalation injury may play a role in overall pulmonary inflammatory response

A study of burn patients has found that those who suffered the most severe smoke inhalation also had more inflammation and spent more time on ventilators and in intensive care.

17 Nov 2011

WSU researchers to study novel antibiotic that may treat VRE infection

The bacteria Enterococcus can cause infections that typically target the digestive tract or bowel; if the bacteria spread, an abdominal abscess or urinary infection could result. Enterococcus also can invade the bloodstream, leading to meningitis, pneumonia or endocarditis - an infection of the heart valve.

17 Nov 2011

Study: Pneumonia the most common serious infection post-heart surgery

Pneumonia - not a deep incision surgical site infection - is the most common serious infection after heart surgery, according to new research presented at the American Heart Association's Scientific Sessions 2011.

16 Nov 2011

Pneumococcal vaccine Prevnar13 effective in seniors

Pneumococcal disease kills millions worldwide and the largest affected groups are children and the elderly. Federal health scientists now assure that the popular pneumococcal vaccine Prevnar is at least as effective as a rival vaccine at protecting adults from the sometimes-deadly infection.

15 Nov 2011

Senior UK Parliamentarians visit Bangladesh to see full impact of pneumonia on children

To mark World Pneumonia Day, a senior UK parliamentary delegation travelled to Dhaka this week to see firsthand the full impact of pneumonia on Bangladeshi children.

14 Nov 2011

IVI receives WHO prequalification for new oral cholera vaccine

Shanchol-, a new oral cholera vaccine developed through the International Vaccine Institute (IVI), an international organization established by the United Nations and based in Seoul, recently received prequalification from the World Health Organization.

13 Nov 2011

Smoke-reducing chimneys prevent pneumonia among young children

Researchers at the University of Liverpool and the universities of California, Berkley and del Valle, Guatemala, have found that cases of severe pneumonia among young children are reduced by one-third in homes with smoke-reducing chimneys on cooking stoves.

11 Nov 2011

Rapid expansion of global vaccine campaign against pneumonia 'unprecedented'

"A global push to bring a vaccine against the bacterial cause of pneumonia to communities that need it most is ramping up quickly, expanding to nearly 60 countries in the next five years," PBS NewsHour's "The Rundown" reports.

11 Nov 2011

Third annual World Pneumonia Day to be observed on Saturday

The third annual World Pneumonia Day will be observed on Saturday.

11 Nov 2011

Wood stoves with chimneys linked to reduced childhood pneumonia

Cooking stoves with chimneys can lower exposure to indoor wood smoke and reduce the rate of severe pneumonia by 30 percent in children less than 18 months of age, according to a new air pollution study funded by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health.

11 Nov 2011